Responses
Clinical pharmacy and clinical trials (including case series)
CPC-132 Syndrome of Inappropriate Antidiuretic Hormone Secretion as Adverse Drug Reaction in Hospitalised Patients Treated with Tolvaptan
Compose a Response to This Article
Other responses
No responses have been published for this article.